Several issues still have to be addressed concerning the role of ILC3 in inflammatory settings: an increase in IL-17A-producing ILC3s was reported in IBD, correlating with mucosal leakage in ulcerative colitis patients (27, 51). Here, IL17A is linked to inflammatory bowel disease.